首页|NRG1、VASH-1水平对ASO患者介入治疗后再狭窄的预测价值

NRG1、VASH-1水平对ASO患者介入治疗后再狭窄的预测价值

扫码查看
目的 探讨血清神经调节蛋白1(NRG1)、血管生成抑制蛋白-1(VASH-1)对下肢动脉硬化闭塞症(ASO)患者介入治疗后再狭窄的预测价值,以期为临床治疗提供参考.方法 选取选取2021年9月-2023年8月宝鸡市中医医院收治的112例ASO患者作为本次研究对象.根据介入治疗6个月后患者是否发生再狭窄分为再狭窄组(n=29)和非再狭窄组(n=83).比较2组患者血清NRG1、VASH-1水平;采用受试者工作特性(ROC)曲线评估血清NRG1、VASH-1对ASO患者介入治疗后再狭窄的预测价值;采用二分类Logistic逐步回归分析探讨ASO患者介入治疗后再狭窄的影响因素.结果 再狭窄组患者NRG1水平低于非再狭窄组,VASH-1水平高于非再狭窄组,差异均有统计学意义(P<0.05).ROC曲线显示,血清NRG1联合VASH-1预测ASO患者介入治疗后再狭窄的曲线下面积(AUC)(95%CI)为0.903(0.852~0.954),特异度为87.11%,灵敏度为86.05%,其预测效能较高.2组患者性别构成、年龄、体质量指数、合并症、病变部位、总胆固醇水平、甘油三酯水平、高密度脂蛋白胆固醇(HDL-C)水平比较,差异均无统计学意义(P>0.05);再狭窄组患者吸烟占比、血管完全闭塞占比、血管病变长度、C反应蛋白(CRP)水平、糖化血红蛋白水平、低密度脂蛋白胆固醇(LDL-C)水平均大于非再狭窄组,差异均有统计学意义(P<0.05).二分类Logistic逐步回归分析结果显示,CRP≥18.74 mg/L、LDL-C≥3.69 mmol/L、NRG1≤16.98 pg/mL、VASH-1 ≥553.49 ng/L是 ASO患者介入治疗后再狭窄的独立危险因素(P<0.05).结论 血清NRG1水平降低、VASH-1水平升高与ASO患者介入治疗后再狭窄之间关系密切,且这2项指标可作为ASO患者介入治疗后再狭窄的重要预测因子.
Predictive value of NRG1 and VASH-1 levels for restenosis in ASO patients after interventional therapy
Objective To explore the predictive value of serum neuregulin-1(NRG1)and vasohibin-1(VASH-1)levels for restenosis in patients with lower limb arteriosclerosis obliterans(ASO)after interventional therapy,providing a reference for clinical treatment.Methods A total of 112 ASO patients treated at Baoji Hospital of Traditional Chinese Medicine from September 2021 to August 2023 were enrolled.Patients were assigned to a restenosis group(n=29)and a non-restenosis group(n=83)based on whether restenosis occurred 6 months after interventional therapy.NRG1 and VASH-1 levels were compared between the two groups.The predictive value of NRG1 and VASH-1 for restenosis was assessed using the receiver operating characteristic(ROC)curve.Binary logistic stepwise regression analysis was used to explore the influencing factors of restenosis after interventional therapy in ASO patients.Results The restenosis group had significantly lower NRG1 lev-els and higher VASH-1 levels than the non-restenosis group(P<0.05).The ROC curve showed that the area under the curve(AUC)for predicting restenosis using serum NRG1 and VASH-1 was 0.903(95%CI:0.852-0.954),with a speci-ficity of 87.11%and a sensitivity of 86.05%,indicating high predictive efficacy.No significant differences were found be-tween the two groups regarding gender,age,body mass index,comorbidities,lesion location,total cholesterol levels,tri-glyceride levels,or HDL-C levels(P>0.05).However,the restenosis group had significantly higher proportions of smok-ers,total occlusion,longer vascular lesions,higher CRP levels,HbA1c levels,and LDL-C levels compared to the non-rest-enosis group(P<0.05).Binary logistic stepwise regression analysis revealed that CRP ≥18.74 mg/L,LDL-C ≥3.69 mmol/L,NRG1 ≤16.98 pg/mL,and VASH-1 ≥553.49 ng/L were independent risk factors for restenosis after interven-tional therapy in ASO patients(P<0.05).Conclusion Lower NRG1 levels and higher VASH-1 levels are closely associat-ed with restenosis after interventional therapy in ASO patients.These two indicators can serve as important predictive fac-tors for restenosis in these patients.

Lower limb arteriosclerosis obliteransRestenosisInterventional therapyNeuregulin-1Vasohibin-1

樊刚、李波、袁涛、齐磊、张华文、樊嘉莹、梁召辉

展开 >

陕西省宝鸡市中医医院介入放射科,陕西 宝鸡 721000

陕西省核工业二一五医院影像科,陕西咸阳 712000

陕西中医药大学中西医结合临床系,陕西咸阳 712046

西安交通大学第一附属医院影像科,西安 710061

展开 >

下肢动脉硬化闭塞症 再狭窄 介入治疗 神经调节蛋白1 血管生成抑制蛋白-1

陕西省科技项目

2023SF-199

2024

保健医学研究与实践
西南大学

保健医学研究与实践

CSTPCD
影响因子:0.512
ISSN:1673-873X
年,卷(期):2024.21(6)